146 results on '"Lysak D"'
Search Results
2. Sensitivity Enhancement in Environmental NMR: Current Technologies and Future Potential
3. FOXO1‐RICTOR AXIS INDUCES AKT PHOSPHORYLATION DURING CLL CELL ADAPTATION TO BCR INHIBITORS: IMPLICATIONS FOR COMBINATORIAL THERAPY
4. Immunotherapy: INVARIANT NKT CELLS CULTURED IN IL2 OR IL15 COULD BE USED AS REGULATORS OF POST-TRANSPLANT COMPLICATIONS
5. CD34+ cell content in unrelated allogeneic peripheral blood stem cell grafts transported internationally. Does the inter-laboratory variability affect comparability of graft quality data?
6. P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP
7. 2DEP cytometry: distributed dielectrophoretic cytometry for live cell dielectric signature measurement on population level
8. Comparison of double transplantation- tandem transplantation or transplantation in relapse - in patients with multiple myeloma: AB92
9. Differences in the characteristics and functions of invariant NKT cells from healthy donors
10. NMR, EPR, and mass spectroscopy estimates of the antiradical activity of water with modified isotope composition
11. THE OPTIMIZATION OF MESENCHYMAL STROMAL CELLS PRODUCTION FOR THE TREATMENT OF STEROID REFRACTORY GRAFT VERSUS HOST DISEASE: PH-AB246
12. REDUCED-INTENSITY TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: SIMILAR RESULTS WITH RELATED OR UNRELATED DONOR, EARLIER INDICATION FOR TRANSPLANTATION COULD IMPROVE RESULTS - SINGLE CENTRE EXPERIENCE: PH-P085
13. THE OUTCOME OF REDUCED-INTENSITY TRANSPLANTATION IN ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN COMPARISON WITH ELDERLY PATIENTS TRANSPLANTED FOR ACUTE MYELOID LEUKEMIA: IS THERE DIFFERENCE IN TIMELINESS OF INDICATION FOR TRANSPLANTATION?: PH-P086
14. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment
15. 1033 - Immunotherapy: INVARIANT NKT CELLS CULTURED IN IL2 OR IL15 COULD BE USED AS REGULATORS OF POST-TRANSPLANT COMPLICATIONS
16. Investigating the nuclear magnetic resonance of the structure of electrolyte based on a LiClO4—ethylene carbonate solution
17. PORTAL VEIN EMBOLIZATION AND STEM CELLS APPLICATION IN PRIMARY UNRESECTABLE COLORECTAL LIVER METASTASES: BF044
18. Studying the internal structure of granular magnetic nanocomposites by ferromagnetic resonance
19. RIC-SCT in 41 consecutive CLL patients from a single centre: unrelated donor provides better disease control with comparable non-relapse mortality: P1154
20. Comparable outcome of unrelated donor and related donor haematopoietic stem cell transplantation for intermediate-risk acute myeloid leukaemia -A singlecentre analysis: P942
21. Quality management system: 3-years experience in a JACIE-accredited centre: P833
22. P03.24 Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients
23. Reduced-intensity transplantation and early withdrawal of immunosuppression in patients with advanced acute myeloid leukaemia - single-centre experience
24. Comparison of patients with acute lymphoblastic leukaemia after related and unrelated stem cell transplantation. Single-centre experience
25. Long-term outcome of patients with diffuse large B-cell lymphoma (DLBCL) in 1.PR treated with autologous transplantation and comparison with DLBCL patients in 1.CR treated identically
26. EXTRANODAL NATURAL KILLER (NK)/T-CELL LYMPHOMA, NASAL TYPE - CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE
27. Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study
28. Atmospheric measurements using the LAMP lidar during the LADIMAS campaign
29. Precise determination of primary cytogenetic abnormalities provides added value for stratification of chronic lymphocytic leukemia patients
30. Portal vein embolization with stem cells application for increasing future liver remnant volume in primary non-resectable colorectal liver metastases
31. Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients
32. Portal vein embolization with stem cells application for enlargement of future liver remnant volume in primary non-resectable colorectal liver metastases
33. Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization.
34. Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia
35. Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients – worldwide battlefield
36. Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment
37. Portal vein embolization and application of autologous stem cells in patients with primary unresectable liver tumours
38. PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech Republic
39. The 2VAL Study: Randomized Comparison of Valganciclovir Vs. Valacyclovir for Cytomegalovirus Prophylaxis after Renal Transplantation
40. Early immunosuppression withdrawal could improve outcome of reduced-intensity transplantation in patients with acute myeloid leukaemia beyond complete remission - single-centre experience
41. Comparable outcome of unrelated donor and related donor haematopoietic stem cell transplantation for intermediate-risk acute myeloid leukaemia - A single-centre analysis
42. REDUCED-INTENSITY TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: SIMILAR RESULTS WITH RELATED OR UNRELATED DONOR, EARLIER INDICATION FOR TRANSPLANTATION COULD IMPROVE RESULTS - SINGLE CENTRE EXPERIENCE
43. Outcome of karyotypic normal FLT3-ITD mutated AML patients treated intentionally with upfront alloHCT - single center experience
44. Comparison of early outcome of CLL patients allotransplanted with conventional or reduced-intensity conditioning: age is no longer a barrier when using reduced-intensity conditioning
45. RIC-SCT in 41 consecutive CLL patients from a single centre: unrelated donor provides better disease control with comparable non-relapse mortality
46. Outcomes of core and extended family donor searches - a single-centre analysis
47. Reduced-intensity transplantation as a part of standard treatment strategy in patients aged 60 to 70 years with acute myeloid leukaemia - single-centre experience
48. Fludarabine plus cyclophosphamide (F+Cy) or F+Cy plus autologous transplantation (Tx) in the treatment of CLL patients
49. Long-term follow-up of a subgroup of peripheral T-cell lymphomas unspecified treated with and without autoSCT
50. First line treatment in patients with mantle cell lymphoma - A three-phase therapy with ASCT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.